Brain­Storm to lay off work­ers; Lil­ly inks a sub­cu­ta­neous deal

Plus, news about Mod­er­na, Caris Life Sci­ences and Ther­at­e­ch­nolo­gies:

Brain­Storm’s lay­offs: Brain­Storm Cell Ther­a­peu­tics said Tues­day it’s let­ting go of 30% of its staffers as it pre­pares to go back to the tri­al de­sign draw­ing board af­ter pulling the BLA for its ALS drug. The “strate­gic re­align­ment” aims to pro­vide more re­sources for a new clin­i­cal tri­al. As of June 30, Brain­Storm em­ployed 44 peo­ple, ac­cord­ing to SEC fil­ings. Brain­Storm re­cent­ly filed its ap­pli­ca­tion for the ALS drug “over protest” de­spite re­ceiv­ing a re­fusal-to-file let­ter from the FDA. The process in­clud­ed an ad­vi­so­ry com­mit­tee hear­ing, where pan­elists vot­ed 17-1 that the drug, called NurOwn, did not demon­strate sub­stan­tial ev­i­dence of ef­fec­tive­ness in a pre­vi­ous study. — Max Gel­man

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER